Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Onset of End-Stage Atrophic Age-Related Macular Degeneration as an End Point-A Delphi Study: Classification of Atrophy Meetings Report 7.
Wu Z, Sadda SR, Ach T, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Curcio CA, Ferris FL 3rd, Fleckenstein M, Freund KB, Grunwald JE, Holz FG, Jaffe GJ, Liakopoulos S, Lim TH, Monés JM, Pagliarini S, Pauleikhoff D, Pfau M, Rosenfeld PJ, Sarraf D, Schmitz-Valckenberg S, Spaide RF, Sparrow JR, Staurenghi G, Tufail A, Viola F, Guymer RH. Wu Z, et al. Among authors: ferris fl 3rd. Ophthalmol Sci. 2025 Mar 28;5(5):100777. doi: 10.1016/j.xops.2025.100777. eCollection 2025 Sep-Oct. Ophthalmol Sci. 2025. PMID: 40469898 Free PMC article.
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.
McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JFE, Emerson SS, Poulter NR, Engelmann MDM, Ripa MS, Hovingh GK, Brown-Frandsen K, Bain SC, Cavender MA, Gislum M, David JP, Buse JB; SOUL Study Group. McGuire DK, et al. N Engl J Med. 2025 May 29;392(20):2001-2012. doi: 10.1056/NEJMoa2501006. Epub 2025 Mar 29. N Engl J Med. 2025. PMID: 40162642 Clinical Trial.
Introduction to the RIMR 2024 special issue.
Csete M, Ferris FL 3rd, Sadda SR. Csete M, et al. Among authors: ferris fl 3rd. Exp Eye Res. 2025 Jun;255:110354. doi: 10.1016/j.exer.2025.110354. Epub 2025 Mar 27. Exp Eye Res. 2025. PMID: 40157628 No abstract available.
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity" [Am J Ophthalmol 2020;219:87-100].
Duncan JL, Liang W, Maguire MG, Audo I, Ayala AR, Birch DG, Carroll J, Cheetham JK, Esposti SD, Durham TA, Erker L, Farsiu S, Ferris FL 3rd, Heon E, Hufnagel RB, Iannaccone A, Jaffe GJ, Kay CN, Michaelides M, Pennesi ME, Sahel JA; Foundation Fighting Blindness Consortium Investigator Group. Duncan JL, et al. Among authors: ferris fl 3rd. Am J Ophthalmol. 2025 May;273:265-266. doi: 10.1016/j.ajo.2025.02.024. Epub 2025 Mar 7. Am J Ophthalmol. 2025. PMID: 40057408 No abstract available.
Visual Acuity, Full-field Stimulus Thresholds, and Electroretinography for 4 Years in The Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) Study.
Birch DG, Cheng P, Maguire MG, Duncan JL, Ayala AR, Cheetham JK, Doucet NR, Durham TA, Fahim AT, Ferris FL 3rd, Huckfeldt RM, Melia M, Michaelides M, Pennesi ME, Sahel JA, Stingl K, Vincent A, Weng CY. Birch DG, et al. Among authors: ferris fl 3rd. Ophthalmol Sci. 2024 Nov 8;5(2):100648. doi: 10.1016/j.xops.2024.100648. eCollection 2025 Mar-Apr. Ophthalmol Sci. 2024. PMID: 39811264 Free PMC article.
Endpoints and Design for Clinical Trials in USH2A-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study.
Maguire MG, Birch DG, Duncan JL, Ayala AR, Ayton LN, Cheetham JK, Cheng P, Durham TA, Ferris FL 3rd, Hoyng CB, Huckfeldt RM, Jaffe GJ, Kay C, Lad EM, Leroy BP, Liang W, McDaniel LS, Melia M, Michaelides M, Pennesi ME, Sahel JA, Samarakoon L; REDI Working Group and the Foundation Fighting Blindness Clinical Consortium Investigator Group. Maguire MG, et al. Among authors: ferris fl 3rd. Transl Vis Sci Technol. 2024 Oct 1;13(10):15. doi: 10.1167/tvst.13.10.15. Transl Vis Sci Technol. 2024. PMID: 39382872 Free PMC article.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
204 results